Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The glycine site on the NMDA receptor is a binding domain on the GluN1 subunit that is essential for receptor activation. Glycine or D-serine must bind to this site simultaneously with glutamate binding to the GluN2 subunit for the ion channel to open. The NMDA receptor plays a critical role in synaptic plasticity, learning, memory, and neurodevelopment. Dysfunction of the glycine site has been implicated in several neurological disorders.
Agonist or antagonist binding to the glycine site on the NMDA receptor modulates channel activity.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on N-methyl-D-aspartate receptor (NMDA) - Glycine Site (None).